Liao C, Nicklaus MC (2009) Comparison of nine programs predicting p \( {\mathit{K _ \rm a \) values of pharmaceutical substances
Because research-market material is sold outside any approved supply chain, its identity and purity are unverified: trial data describe a characterized study drug, not the contents of an arbitrary vial, so a batch certificate of analysis is the minimum a research setting should require
The Drugs@FDA database contains no entry for BPC-157 in any indication, and ClinicalTrials.gov shows no ongoing human studies registered in the United States
"Your firm manufactured multiple GLP-1 finished drug products such as sterile, multi-dose vials of semaglutide and tirzepatide, without appropriate procedures to prevent microbiological contamination of your drug products, purporting to be sterile," said FDA
The BDNF increase from fasting appears to be related to the switch from glucose to ketone metabolism, as ketone bodies like beta-hydroxybutyrate directly stimulate BDNF gene expression in the hippocampus
The PCAC is considering these seven peptide substances in a meeting July 23-24: BPC-157, KPV, TB-500, MOTS-C, Semax, Epitalon, Emideltide
